Assignee
SHANGHAI ZHIMENG BIOPHARMA INC
CN·6 granted patents·5 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
11 records- 0170US12157726B2P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2022·Granted Dec 3, 2024·0 cites·11 claims
- 0265US12319656B2Compound as potassium channel regulator and preparation and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2021·Granted Jun 3, 2025·0 cites·10 claims
- 0360US2024368143A1Crystal form of compound represented by formula i, and preparation therefor and application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0460US2024336607A1Preparation method for hepatitis b virus nucleocapsid inhibitorSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0560US2025109107A1Aromatic ring-fused heterocyclic ring compound as potassium channel regulator, and preparation therefor and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0660US2025144115A1Amide compound as potassium channel regulator, and preparation therefor and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0754US2023077155A1Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0853US11365181B2P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2019·Granted Jun 21, 2022·0 cites·9 claims
- 0952US12473276B2Compound having neuroprotective effect, preparation method therefor and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2020·Granted Nov 18, 2025·0 cites·8 claims
- 1051US12492170B2Tetrahydro-1H-benzazepine compound as potassium channel modulator, preparation method and use thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2020·Granted Dec 9, 2025·0 cites·9 claims
- 1149US12486265B22-aminopyrimidine compounds and pharmaceutical compositions and uses thereofSHANGHAI ZHIMENG BIOPHARMA INC·Filed 2020·Granted Dec 2, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI ZHIMENG BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →